Operating Lease, Right-of-Use Asset in USD of Dolby Laboratories, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dolby Laboratories, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q3 2019 to Q3 2025.
  • Dolby Laboratories, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 26 Sep 2025 was $33,204,000.000, a 15% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Dolby Laboratories, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $33,204,000 -$5,842,000 -15% 26 Sep 2025 10-K 18 Nov 2025
Q2 2025 $32,948,000 -$6,909,000 -17.3% 27 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $34,086,000 -$8,971,000 -20.8% 28 Mar 2025 10-Q 01 May 2025
Q4 2024 $36,972,000 -$1,029,000 -2.7% 27 Dec 2024 10-Q 30 Jan 2025
Q3 2024 $39,046,000 -$1,153,000 -2.9% 27 Sep 2024 10-K 18 Nov 2025
Q2 2024 $39,857,000 +$584,000 +1.5% 28 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $43,057,000 -$1,664,000 -3.7% 29 Mar 2024 10-Q 02 May 2024
Q4 2023 $38,001,000 -$5,354,000 -12.3% 29 Dec 2023 10-Q 02 Feb 2024
Q3 2023 $40,199,000 -$6,331,000 -13.6% 29 Sep 2023 10-K 19 Nov 2024
Q2 2023 $39,273,000 -$14,429,000 -26.9% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $44,721,000 -$14,213,000 -24.1% 31 Mar 2023 10-Q 05 May 2023
Q4 2022 $43,355,000 -$19,786,000 -31.3% 30 Dec 2022 10-Q 02 Feb 2023
Q3 2022 $46,530,000 -$20,598,000 -30.7% 30 Sep 2022 10-K 17 Nov 2023
Q2 2022 $53,702,000 -$17,923,000 -25% 01 Jul 2022 10-Q 09 Aug 2022
Q1 2022 $58,934,000 -$13,042,000 -18.1% 01 Apr 2022 10-Q 05 May 2022
Q4 2021 $63,141,000 -$12,319,000 -16.3% 31 Dec 2021 10-Q 04 Feb 2022
Q3 2021 $67,128,000 -$9,387,000 -12.3% 24 Sep 2021 10-K 18 Nov 2022
Q2 2021 $71,625,000 -$6,749,000 -8.6% 25 Jun 2021 10-Q 29 Jul 2021
Q1 2021 $71,976,000 -$7,463,000 -9.4% 26 Mar 2021 10-Q 04 May 2021
Q4 2020 $75,460,000 +$4,389,000 +6.2% 25 Dec 2020 10-Q 29 Jan 2021
Q3 2020 $76,515,000 +$14,415,000 +23.2% 25 Sep 2020 10-K 17 Nov 2021
Q2 2020 $78,374,000 26 Jun 2020 10-Q 03 Aug 2020
Q1 2020 $79,439,000 27 Mar 2020 10-Q 04 May 2020
Q4 2019 $71,071,000 27 Dec 2019 10-Q 29 Jan 2020
Q3 2019 $62,100,000 28 Sep 2019 10-K 16 Nov 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.